One man to have already benefited from the advances in precision medicine is leukaemia sufferer Mike Brandon.
The 34-year-old from Bristol was desperately ill when he underwent pioneering CAR T therapy in the US city of Philadelphia in 2016.
Mike was suffering from chronic lymphocytic leukaemia (CLL), which is not considered to be curable. He underwent a successful bone marrow transplant in 2014 after first being diagnosed but suffered a full-blown relapse two years later.
His wife Kate spearheaded a crowdfunding drive when they discovered that the experimental treatment was not yet licensed in Europe and raised more than £400,000 in just nine days.
Read more here: dailymail.co.uk/health/arti...
